(Q45744202)

15 December 2017

title

HLA association with hepatitis C virus infection (English)

1 reference

15 December 2017

1 reference

1 reference

Vejbaesya S

1

1 reference

15 December 2017

Songsivilai S

2

1 reference

15 December 2017

Tanwandee T

3

1 reference

15 December 2017

Rachaibun S

4

1 reference

15 December 2017

Chantangpol R

5

1 reference

15 December 2017

Dharakul T

6

1 reference

15 December 2017

language of work or name

1 reference

1 March 2000

1 reference

15 December 2017

published in

Human Immunology

1 reference

15 December 2017

volume

61

1 reference

15 December 2017

page(s)

348-353

1 reference

15 December 2017

issue

3

1 reference

15 December 2017

The prevalence of hepatitis C virus antibody in high risk group of Thai children and adults

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900131-7

7 January 2021

Prevalence of hepatitis C virus antibody among healthy blood donors and non-A, non-B hepatitis patients in Thailand.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900131-7

7 January 2021

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900131-7

7 January 2021

Hepatitis C virus genotypes in patients with hepatocellular carcinoma and cholangiocarcinoma in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900131-7

7 January 2021

Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900131-7

7 January 2021

Persistent hepatitis C viraemia without liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900131-7

7 January 2021

HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900131-7

7 January 2021

Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900131-7

7 January 2021

Association between MHC Class II Alleles and Clearance of Circulating Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900131-7

7 January 2021

Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900131-7

7 January 2021

HLA-A, -B, -DRB1, -DQA1, and -DQB1 polymorphism in Thais

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900131-7

7 January 2021

On estimating the relation between blood group and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900131-7

7 January 2021

T-lymphocyte response to hepatitis C virus in different clinical courses of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900131-7

7 January 2021

Immunopathology of hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900131-7

7 January 2021

Absence of association between HLA antigens and chronicity of viral hepatitis in haemodialyzed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900131-7

7 January 2021

No significant influence of HLA determinants on susceptibility to hepatitis C virus infection in Caucasian patients with end-stage renal disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0198-8859%2899%2900131-7

7 January 2021

10.1016/S0198-8859(99)00131-7

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

10689128

1 reference

15 December 2017